1. Introduction
===============

Lung cancer is the leading cause of cancer-related deaths in Taiwan and other countries \[[@B1-molecules-19-19892]\]. So far, the 5-year survival rate for lung cancer patients after surgical treatment combined with other therapies is very low \[[@B2-molecules-19-19892]\]. Thus, the development of agents with cytotoxic activity for lung cancer cells is important in order to improve lung cancer therapy.

Cancer cell death can be induced by activating the mitochondrial apoptotic pathway. This pathway is mainly mediated by BCL family proteins, in which the expression of apoptotic factors such as Bax is increased, and the expression of anti-apoptotic factors such as Bcl-2 is decreased \[[@B3-molecules-19-19892]\]. The changes in these BCL family proteins trigger permeabilization of the outer mitochondrial membrane, which leads to the loss of mitochondrial membrane potential (MMP) \[[@B4-molecules-19-19892]\], causes the release of cytochrome c and apoptosis-inducing factor (AIF), as well as activates mitochondria-derived caspase cascade \[[@B5-molecules-19-19892],[@B6-molecules-19-19892],[@B7-molecules-19-19892]\]. These events eventually result in cell death. Na^+^-K^+^-ATPase, a key enzyme of TCA cycle, is a transmembrane protein responsible for exchanging intracellular Na^+^ for extracellular K^+^ \[[@B8-molecules-19-19892]\]. Abnormality in this enzyme disturbs ion homeostasis and impairs mitochondrial functions \[[@B9-molecules-19-19892]\]. Thus, any agent with the effects to alter Bcl-2, MMP, Na^+^-K^+^-ATPase and/or caspases in lung cancer cells may induce mitochondrial mediated apoptosis.

Malignant tumor growth creates a hypoxic environment because of insufficient blood supply. Under these hypoxic conditions, hypoxia-inducible factor (HIF)-1α is overexpressed and enhances the transcription of several genes encoded for angiogenic and autocrine growth factors, including vascular endothelial growth factor (VEGF), survivin and inducible nitric oxide synthase (iNOS), which consequently promote cancer cell proliferation and metastasis \[[@B10-molecules-19-19892],[@B11-molecules-19-19892]\]. Tumor hypoxia is highly associated with resistance to many chemotherapeutic drugs, and high tumor vascular density is negatively correlated with patient survival outcome \[[@B12-molecules-19-19892]\]. Therefore, any agent with the capability to suppress HIF-1α expression under hypoxic condition may provide more efficient anti-cancer activity.

Maslinic acid (MA) is a pentacyclic triterpenic acid naturally occurring in many plant foods such as hawthorn fruit (*Crataegi Pinnatifidae* Fructus), basil (*Ocimum basilicum*), brown mustard (*Brassica juncea*) and olive (*Olea europaea* L.) \[[@B13-molecules-19-19892],[@B14-molecules-19-19892]\]. The inhibitory effects of this triterpene against colon, prostate and bladder cancer cells under normoxic conditions have been reported \[[@B15-molecules-19-19892],[@B16-molecules-19-19892],[@B17-molecules-19-19892]\]. Our previous study found that MA attenuated invasion and migration of three hepatic cancer cell lines under normoxic conditions \[[@B18-molecules-19-19892]\]. Those previous studies indicated that this triterpene was a potent anti-cancer agent. However, it remains unknown whether MA could inhibit the growth of lung cancer cells, especially under hypoxic conditions.

In our present study, A549 cell line, a lung adenocarcinoma cell line, was used to examine the apoptotic effects and possible mode(s) of action of MA at various doses under normaxic and hypoxic conditions. The impact of this triterpene upon the level, activity and/or protein expression of HIF-1α, survivin, AIF and associated apoptotic factors under both conditions was evaluated and compared.

2. Results and Discussion
=========================

2.1. Results
------------

### 2.1.1. Effects of MA upon Cell Viability

MA treatments at the test doses led to viability of HBE cells in the range of 98%--103% and 95%--100% under normoxic and hypoxic conditions ([Figure 1](#molecules-19-19892-f001){ref-type="fig"}). MA treatments at 8--64 μmol/L inhibited the growth of A549 cells under both conditions (*p* \< 0.05), in which MA at each test dose caused lower viability under normoxic conditions than under hypoxic conditions (*p* \< 0.05).

![Effects of MA at 0, 4, 8, 16, 32 or 64 μmol/L upon viability in HBE cells and A549 cells under normoxic and hypoxic conditions. Data are mean ± SD (*n* = 10). ^\#^ Means significantly different from normoxic group at the same dose at *p* \< 0.05.](molecules-19-19892-g001){#molecules-19-19892-f001}

### 2.1.2. Effects of MA upon Mitochondrial Apoptotic Pathway

MA treatments did not affect protein expression of cleaved caspase-3, Bax and Bcl-2 in HBE cells ([Figure 2](#molecules-19-19892-f002){ref-type="fig"}, *p* \> 0.05). MA at 4--64 μmol/L increased cleaved caspase-3 expression under both conditions; in which MA at 8--64 μmol/L under normoxic conditions led to greater cleaved caspase-3 expression than under hypoxic conditions (*p* \< 0.05). MA at 4--64 μmol/L decreased Bcl-2 expression under normoxic conditions; but under hypoxic conditions, Bcl-2 expression was reduced by MA at 16--64 μmol/L (*p* \< 0.05). Compared with hypoxic conditions, MA at each dose under normoxic conditions caused a greater decrease of Bcl-2 expression (*p* \< 0.05). Bax expression under normoxic conditions was up-regulated by MA at 16--64 μmol/L (*p* \< 0.05); however, MA treatments did not affect Bax expression under hypoxic conditions (*p* \> 0.05).

![Effects of MA at 0, 4, 8, 16, 32 or 64 μmol/L upon cleaved caspase-3, Bcl-2 and Bax expression in HBE cells and A549 cells under normoxic and hypoxic conditions. Data are mean ± SD (*n* = 10).](molecules-19-19892-g002){#molecules-19-19892-f002}

As shown in [Figure 3](#molecules-19-19892-f003){ref-type="fig"}, MA at 4--64 μmol/L and 8--64 μmol/L, respectively, decreased Na^+^-K^+^-ATPase activity under normoxic and hypoxic conditions (*p* \< 0.05). Compared with hypoxic conditions, MA at each dose under normoxic conditions led to greater decline in Na^+^-K^+^-ATPase activity (*p* \< 0.05). MA reduced MMP under both conditions at 8--64 μmol/L (*p* \< 0.05), in which MA led to greater MMP reduction under normoxic conditions than under hypoxic conditions (*p* \< 0.05). MA dose-dependently raised caspase-3 activity under both conditions ([Figure 4](#molecules-19-19892-f004){ref-type="fig"}, *p* \< 0.05); and there was no significantly different at each dose between these two conditions (*p* \> 0.05). MA increased caspase-8 activity under normoxic and hypoxic conditions at 8--64 μmol/L and 16--64 μmol/L, respectively. Compared with hypoxic conditions, MA at 8--64 μmol/L under normoxic conditions led to greater increase in caspase-8 activity (*p* \< 0.05). As shown in [Figure 5](#molecules-19-19892-f005){ref-type="fig"}, MA dose-dependently increased caspase-3 expression under normoxic conditions; however, under hypoxic conditions, caspase-3 expression could be enhanced by MA at 8--64 μmol/L (*p* \< 0.05). MA increased caspase-8, cytosolic cytochrome c and AIF expression under normoxic and hypoxic conditions at 8--64 μmol/L and 32--64 μmol/L, respectively. Compared with hypoxic conditions, MA at 8--64 μmol/L under normoxic conditions led to greater caspase-8, cytochrome c and AIF expression (*p* \< 0.05).

![Effects of MA at 0, 4, 8, 16, 32 or 64 μmol/L upon Na^+^-K^+^-ATPase activity and mitochondrial membrane potential (MMP) in A549 cells under normoxic and hypoxic conditions. Data are mean ± SD (*n* = 10). ^a--e^ Means among bars in the same condition without a common letter differ, *p* \< 0.05. ^\#^ Means significantly different from normoxic conditions at the same dose at *p* \< 0.05.](molecules-19-19892-g003){#molecules-19-19892-f003}

###### 

Effects of MA at 0, 4, 8, 16, 32 or 64 μmol/L upon activity of caspase-3 and caspase-8 in A549 cells under normoxic and hypoxic conditions. Data are mean ± SD (*n* = 10). ^a--e^ Means among bars in the same condition without a common letter differ, *p* \< 0.05. ^\#^ Means significantly different from normoxic conditions at the same dose at *p* \< 0.05.

![](molecules-19-19892-g004a)

![](molecules-19-19892-g004b)

![Effects of MA at 0, 4, 8, 16, 32 or 64 μmol/L upon caspase-3, caspase-8, cytosolic cytochrome c and AIF expression in A549 cells under normoxic and hypoxic conditions. Data are mean ± SD (*n* = 10).](molecules-19-19892-g005){#molecules-19-19892-f005}

### 2.1.3. Effects of MA on the HIF-1α Pathway

MA down-regulated HIF-1α and VEGF expression under normoxic and hypoxic conditions at 8--64 and 16--64 μmol/L, respectively ([Figure 6](#molecules-19-19892-f006){ref-type="fig"}, *p* \< 0.05). MA at 8--64 μmol/L lowered survivin and iNOS expression under normoxic condition (*p* \< 0.05); however, under hypoxic conditions, the expression of survivin and iNOS was decreased by MA at 32--64 μmol/L (*p* \< 0.05). Compared with hypoxic conditions, MA at 8--64 μmol/L under normoxic conditions caused a greater reduction in HIF-1α, VEGF, survivin and iNOS expression (*p* \< 0.05). After A549 cells were treated by YC-1, an inhibitor of HIF-1α, MA did not affect the protein expression of HIF-1α, VEGF, survivin and iNOS ([Figure 7](#molecules-19-19892-f007){ref-type="fig"}, *p* \> 0.05). Without MA treatment, hypoxic conditions led to greater ROS and NO production than normoxic condition ([Table 1](#molecules-19-19892-t001){ref-type="table"}, *p* \< 0.05). MA lowered ROS levels under normoxic and hypoxic conditions at 4--64 and 8--64 μmol/L, respectively (*p* \< 0.05). MA decreased NO levels at 8--64 and 32--64 μmol/L, respectively, under normoxic and hypoxic conditions (*p* \< 0.05).

![Effects of MA at 0, 4, 8, 16, 32 or 64 μmol/L upon HIF-1α, VEGF, survivin and iNOS expression in A549 cells under normoxic and hypoxic conditions. Data are mean ± SD (*n* = 10).](molecules-19-19892-g006){#molecules-19-19892-f006}

![Effects of YC-1 and MA at 0, 4, 8, 16, 32 or 64 μmol/L upon HIF-1α, VEGF, survivin and iNOS expression in A549 cells under normoxic and hypoxic conditions. Data are mean ± SD (*n* = 10).](molecules-19-19892-g007){#molecules-19-19892-f007}

molecules-19-19892-t001_Table 1

###### 

Effects of MA at 0, 4, 8, 16, 32 or 64 μmol/L upon level of ROS (nmol/mg protein) and NO (μM/mg protein) in A549 cells under normoxic and hypoxic conditions. Data are mean ± SD (*n* = 10).

  ROS                                
  ---------------- ----------------- --------------------
  0                1.91 ± 0.21 ^e^   2.45 ± 0.28 ^d,\#^
  4                1.58 ± 0.24 ^d^   2.30 ± 0.2 ^d,\#^
  8                1.23 ± 0.16 ^c^   1.88 ± 0.19 ^c,\#^
  16               0.90 ± 0.08 ^b^   1.43 ± 0.13 ^b,\#^
  32               0.53 ± 0.11 ^a^   1.02 ± 0.07 ^a,\#^
  64               0.37 ± 0.09 ^a^   0.87 ± 0.12 ^a,\#^
  **NO**                             
  **MA, μmol/L**   **Normoxic**      **Hypoxic**
  0                14.9 ± 1.1 ^c^    19.0 ± 1.8 ^b,\#^
  4                14.5 ± 1.3 ^c^    18.3 ± 2.0 ^b,\#^
  8                11.7 ± 0.8 ^b^    17.8 ± 1.4 ^b,\#^
  16               11.1 ± 1.0 ^b^    17.2 ± 1.2 ^b,\#^
  32               8.0 ± 0.5 ^a^     12.4 ± 0.9 ^a,\#^
  64               6.4 ± 0.7 ^a^     11.3 ± 1.1 ^a,\#^

^a--e^ Means values in a column without a common letter differ, *p* \< 0.05. ^\#^ Means significantly different from normoxic conditions at the same dose at *p* \< 0.05.

2.2. Discussion
---------------

In our present study, MA at the tested doses did not affect the survival of human bronchial epithelial cells. This agent thus seems safe for normal upper respiratory system cells at these doses. However, we found that MA markedly induced apoptosis in A549 cells under normoxic and hypoxic conditions by mediating both the mitochondrial apoptotic pathway and the HIF-1α signaling pathway. These findings supported the potential of this triterpenoid acid as an anti-lung cancer agent.

BCL family molecules are involved in the mitochondrial-mediated apoptotic pathway, in which Bcl-2 is an anti-apoptotic molecule, and Bax and cleaved caspase-3 are pro-apoptotic molecules \[[@B19-molecules-19-19892]\]. We found MA down-regulated Bcl-2 expression and up-regulated cleaved caspase-3 and/or Bax expression in A549 cells under both conditions, which consequently diminished anti-apoptotic defense and enhanced apoptotic stress. These results suggest that MA could penetrate into A549 cells and induce apoptosis through the mitochondria-mediated intrinsic apoptotic pathway. In addition, we observed that MA increased Bax expression under normoxic conditions, but not under hypoxic conditions. It was possible that hypoxia affected MA activity, and weakened the cytotoxic efficiency of MA to A549 cells under this condition.

Na^+^-K^+^-ATPase is responsible for ion homeostasis of plasma membranes. Abnormal Na^+^-K^+^-ATPase activity led to the loss of mitochondrial membrane potential and the release of caspases \[[@B20-molecules-19-19892],[@B21-molecules-19-19892]\]. Caspases include two subfamilies: upstream initiator caspases such as caspases-8, which are involved in regulatory events; and downstream executor caspases such as caspases-3, which directly respond to the change in cell morphological events \[[@B22-molecules-19-19892]\]. The activation of these caspases mediates kinases or phosphatases to alter signal transduction and gene expression, which eventually results in proteolytic cleavage, DNA damage and cell death. In our present study, MA decreased Na^+^-K^+^-ATPase activity and mitochondrial membrane potential, and in turn contributed to enhance the activity and protein expression of caspase-8 and caspase-3. These results indicated that MA executed its cytotoxic actions toward A549 cells by disturbing mitochondrial membrane integrity and activating both upstream and downstream caspases, which consequently promoted cell apoptosis. In addition, the activated caspase-8 in MA treated cells implied that death receptor-mediated extrinsic apoptotic pathway was also involved in MA induced apoptosis, especially under normoxic conditions, because signaling transduction in this pathway was critically dependent on caspase-8 \[[@B23-molecules-19-19892]\]. Compared with normoxic conditions, MA was less efficiency in raising caspase-8 activity and protein expression under hypoxic conditions. These data partially explained the lesser inhibitory effects of MA on A549 cells under hypoxic conditions. In addition, both cytochrome c and AIF play important roles in mitochondrial respiratory chain and are required for cell survival \[[@B24-molecules-19-19892],[@B25-molecules-19-19892]\]. Thus, the increased release of these molecules from mitochondrial inter-membrane in MA-treated A549 cells under both conditions agreed that MA elicited mitochondrial membrane rupture and impaired mitochondrial respiratory chain in those cells. These findings once again supported that mitochondrial dependent pathway was involved in MA induced A549 cell apoptosis.

HIF-1α is a crucial activator responsible for lung cancer progression because it regulates the essential adaptive process for cancer cells to hypoxia, the major pathophysiological condition \[[@B26-molecules-19-19892],[@B27-molecules-19-19892]\]. Furthermore, activated HIF-1α promotes the expression of VEGF, survivin and iNOS \[[@B11-molecules-19-19892],[@B27-molecules-19-19892],[@B28-molecules-19-19892]\], which subsequently benefits neovascularization and metastasis. In our present study, hypoxia markedly enhanced HIF-1α expression in A549 cells. Thus, it was reasonable to observe greater protein expression of VEGF, survivin and iNOS in those cells under this condition. However, we found that MA treatments effectively down-regulated HIF-1α expression, especially under normoxic conditions. Since HIF-1α expression has been declined, the lower expression of its downstream molecules, VEGF, survivin and iNOS, could be explained. These data suggested that MA could mediate HIF-1α pathway. Furthermore, we found the presence of YC-1 completely blocked the regulation of MA upon the expression of HIF-1α and its target molecules under both conditions. These findings once again supported that the anti-lung cancer action of MA was dependent on its suppression upon HIF-1α. Compared with normoxic conditions, MA was less effective at down-regulating HIF-1α under hypoxic conditions. It is possible that hypoxia induced too much HIF-1α for MA to counteract. The other possibility was that MA exhibited poor interaction with HIF-1α under this condition. These results implied that higher MA doses might be necessary in order to overcome hypoxia and carry out its anti-lung cancer action.

ROS could stimulate HIF-1α and VEGF expression, and mediate the mitochondrial apoptotic pathway \[[@B29-molecules-19-19892],[@B30-molecules-19-19892]\]. Nitric oxide could promote cell-cell aggregation and enhance mesenchymal to epithelial transition process in lung cancer cells \[[@B31-molecules-19-19892]\]. These events favor lung cancer development and progression. We found that hypoxia remarkably increased ROS and NO production in A549 cells, which explained the beneficial effects of hypoxia upon lung cancer progression. It is reported that MA could scavenge ROS and NO \[[@B32-molecules-19-19892],[@B33-molecules-19-19892]\]. It seems reasonable to observe lower ROS and NO production in MA-treated A549 cells. Thus, it is possible that MA declined HIF-1α and VEGF expression partially through decreasing ROS and NO formation. These results suggested that the anti-oxidative activity of MA might also contribute to its anti-lung cancer activities. MA is a triterpene occurring in many plant foods such as gynara, basil and brown mustard \[[@B14-molecules-19-19892]\], or botanicals used as food supplement ingredients \[[@B34-molecules-19-19892]\]. Consumers could obtain MA through dietary intake of some plant foods rich in this compound. It is reported that a single oral administration of MA at 1000 mg/kg to mice did not produce any signs of morbidity or mortality; and daily MA oral administration at 50 mg/kg for 28 days did not induce any sign of toxicity in mice \[[@B35-molecules-19-19892]\]. This agent seems safe for application.

3. Experimental Section
=======================

3.1. Materials
--------------

Maslinic acid (MA, 97.5%) was kindly provided by Wen-wei Qiu (East China Normal University, Shanghai, China). YC-1 (HIF-1α inhibitor) was purchased from Cell Signaling Technology (Boston, MA, USA). Normal human bronchial epithelial cell (HBE) and human lung cancer A549 cell lines were obtained from American Type Culture Collection (ATCC, Rockville, MD, USA). Medium, plates, antibiotics and chemicals used for cell culture were purchased from Difco (Detroit, MI, USA).

3.2. Experimental Design and Cell Culture
-----------------------------------------

Stock solution of MA was prepared in dimethyl sulfoxide (DMSO) and diluted with RPMI 1640 medium. The final DMSO concentration in cell culture was lower than 0.5%. At this concentration, DMSO did not affect any measurements (data not shown). Cells were routinely cultured in RPMI 1640 medium, containing 10% fetal bovine serum, 100 units/mL of penicillin and 100 units/mL of streptomycin (pH 7.4) at 37 °C under normoxic conditions, 95% air and 5% CO~2~. The culture medium was changed every three days, and cells were subcultured once a week. A phosphate buffer saline (PBS, pH 7.2) was added to adjust the cell number to 10^5^/mL for various experiments and analyses. Cells were treated with MA at 0 (control), 4, 8, 16, 32 or 64 μmol/L at 37 °C for 72 h under normoxic or hypoxic conditions, 1% O~2~, 94% N~2~ and 5% CO~2~, which resulted in 96.3% ± 1.1% and 94.8% ± 1.4% MA incorporation into cells under two conditions. In order to clarify the role of MA on HIF-1α, cells were pretreated with 10 μM YC-1 for 60 min before culture.

3.3. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide (MTT) Assay
-----------------------------------------------------------------------------

MTT assay was performed to examine cell viability. Briefly, cells at 10^5^/mL were incubated with 0.25 mg MTT/mL for 3 h at 37 °C. The amount of MTT formazan product was determined by measuring absorbance at 570 nm (630 nm as a reference) using a microplate reader (Bio-Rad, Hercules, CA, USA). Cell viability was expressed as a percentage of control groups.

3.4. Preparation of Mitochondrial Fractions
-------------------------------------------

Control or treated cells were lysed in 5 mL cold lysis buffer containing 10 mM HEPES (pH 7.9), 1.5 mM MgCl~2~, 10 mM KCl, 0.1 mM EDTA, 1 mM DTT, 1 mM PMSF and 0.6% Nonidet P-40 for 30 min, and centrifuged at 200*×g* for 10 min at 4 °C to obtain nuclei pellet. The supernatant from this spin was further centrifuged at 10,000*×g* for 20 min at 4 °C to obtain mitochondria pellet. This pellet was re-suspended by PBS. Protein concentration of mitochondrial fraction was determined by a commercial assay kit (Pierce Biotechnology Inc., Rockford, IL, USA) with bovine serum albumin as a standard. Sample was diluted with PBS to a final concentration of 1 mg protein/mL for further use.

3.5. Na^+^-K^+^-ATPase Activity Assay
-------------------------------------

Na^+^-K^+^-ATPase activity was detected by measuring the amount of inorganic phosphate (Pi) released from ATP \[[@B36-molecules-19-19892]\]. The reaction mixture contained freshly isolated cellular mitochondrial fraction and 100 mM NaCl, 20 mM KCl, 2 mM ATP, 30 mM Tris-HCl buffer (pH 7.4). This assay was initiated by adding 100 μL 1 mM Tris-ATP to 0.5 mL sample, and terminated by adding 100 μL 15% trichloroacetic acid after 15 min incubation at 37 °C. The released Pi level was assayed by measuring the absorbance at 640 nm. The value of treated cells was expressed as a percentage of control groups.

3.6. Measurement of MMP
-----------------------

MMP was monitored by using a flow cytometry (Beckman-FC500, Beckman Coulter, Fullerton, CA, USA) and the fluorescent dye rhodamine 123 (Rh123) purchased from Sigma Chemical Co. (St. Louis, MO, USA). Cells were washed and suspended in RPMI 1640 medium. Rh123 (100 μg/L) was added to cells at 10^5^/mL and incubated for 45 min at 37 °C. After washed twice with PBS, the mean fluorescence intensity (MFI) in cells was analyzed with flow cytometry.

3.7. Measurement of Caspase Activity
------------------------------------

Activity of caspase-3 and -8 was detected by fluorometric assay kits (Upstate, Lake Placid, NY, USA) according to the manufacturer's protocol. In brief, cells at 10^5^/mL were lysed in 5 mL cold lysis buffer and incubated on ice for 10 min. Fifty μL cell lysates were mixed with 5 mL reaction buffer and 2.5 mL fluorogenic substrates specific for caspase-3 or -8. After incubation at 37 °C for 1 h, fluorescent activity was measured by using a F-4500 fluorophotometer (Hitachi, Tokyo, Japan) with excitation at 400 nm and emission at 505 nm. Data were expressed as a percentage of control groups.

3.8. Reactive Oxygen Species (ROS) and Nitric Oxide (NO) Assays
---------------------------------------------------------------

The dye 2\',7\'-dichlorodihydrofluorescein diacetate (Aldrich Chemical Co., Milwaukee, WI, USA) was used to measure ROS level. Briefly, cells at 10^5^/mL were washed and suspended in RPMI 1640 medium. After incubating with 50 μmol/L dye for 30 min, fluorescence changes were measured at an excitation wavelength of 485 nm and an emission wavelength of 530 nm by a fluorescence microplate reader. The production of NO was determined by measuring the formation of nitrite. Cells were lysed and centrifuged at 2000× *g* for 10 min at 4 °C. Cell supernatant was treated with nitrate reductase, NADPH and FAD, and followed by incubation for 1 h at 37 °C in the dark. Then, 100 μL sample was mixed with 100 µL Griess reagent for color development. The absorbance at 540 nm was measured and compared with a sodium nitrite standard curve.

3.9. Western Blot Analyses
--------------------------

Cells were suspended in above lysis buffer, and protein content was determined by Bio-Rad protein assay reagent (Bio-Rad Laboratories Inc. Hercules, CA, USA). Protein sample at 40 μg was applied to 10% SDS-polyacrylamide gel electrophoresis, and transferred to a nitrocellulose membrane (Millipore, Bedford, MA, USA) for 1 h. After blocking with a solution containing 5% nonfat milk for 1 h to prevent non-specific binding of antibody, membrane was incubated with anti-cleaved caspase-3, anti-Bcl-2, anti-Bax (1:2000), anti-caspase-3, anti-caspase-8, anti-cytochrome c, anti-AIF (1:500); anti-HIF-1α, anti-VEGF, anti-survivin and anti-iNOS (1:1000) monoclonal antibody (Boehringer-Mannheim, Indianapolis, IN, USA) at 4 °C overnight, and followed by reacting with horseradish peroxidase-conjugated antibody for 3.5 h at room temperature. The detected bands were quantified by an image analyzer (ATTO, Tokyo, Japan) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. The blot was quantified by densitometric analysis. Results were normalized to GAPDH.

3.10. Statistical Analysis
--------------------------

The effect of each treatment was analyzed from ten different preparations (*n* = 10). Data were reported as means ± standard deviation (SD). Statistical differences between doses, and between conditions were evaluated by 2-way ANOVA and Bonferroni's post test. *p* \< 0.05 level was considered to be significantly different.

4. Conclusions
==============

Maslinic acid treatments caused A549 cells apoptosis via mediating mitochondrial apoptotic pathway and HIF-1α pathway under normoxic and hypoxic conditions. Schematic diagram for activities of MA is shown in [Figure 8](#molecules-19-19892-f008){ref-type="fig"}.

![Schematic diagram for cytotoxic effects of maslinic acid toward A549 cells.](molecules-19-19892-g008){#molecules-19-19892-f008}

These findings support that maslinic acid is a potent agent against lung cancer.
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